Follow up of beta hcg after methotrexate
Reading File
Finding Sources
Finding Sources
Searching PubMed
"ectopic pregnancy" AND "methotrexate" AND "beta hCG" monitoring
Finding Sources
Finding Sources
Searching PubMed
"ectopic pregnancy" AND "methotrexate" AND "serum hCG"
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have all the key information needed. Let me compose the comprehensive answer.
Beta-hCG Follow-up After Methotrexate (for Ectopic Pregnancy)
The monitoring schedule depends on which dosing regimen was used. All three published regimens use the same 15% drop threshold as the marker of adequate response.
Single-Dose Regimen (MTX 50 mg/m² on Day 0)
| Day | Action |
|---|---|
| Day 0 | Give MTX 50 mg/m² IM; record baseline β-hCG |
| Day 4 | Draw β-hCG |
| Day 7 | Draw β-hCG; compare to Day 4 value |
| Weekly thereafter | β-hCG until non-pregnant level (< 5 mIU/mL) |
Decision on Day 7:
- β-hCG drops ≥ 15% from Day 4 to Day 7 → Treatment is working; continue weekly monitoring until undetectable.
- β-hCG drops < 15% → Repeat MTX dose (50 mg/m²) and restart the Day 4/7 monitoring cycle.
Important note on the Day 1-4 rise: It is normal and expected for β-hCG to rise between Day 1 and Day 4. This is not treatment failure. Only the Day 4→Day 7 change is the decision point.
- 15-25% of patients require a second dose.
- Failure risk is 14.3% if initial β-hCG > 5,000 mIU/mL vs. only 3.7% if < 5,000 mIU/mL.
Two-Dose Regimen (MTX 50 mg/m² on Days 0 and 4)
| Day | Action |
|---|---|
| Day 0 | MTX 50 mg/m² IM |
| Day 4 | MTX 50 mg/m² IM; draw β-hCG |
| Day 7 | Draw β-hCG; compare to Day 4 |
| Days 7 + 11 | If < 15% drop: give repeat MTX on Days 7 and 11; draw β-hCG on Days 11 and 14 |
| Weekly | Once 15% drop confirmed, weekly β-hCG until non-pregnant |
Success rate ~87%.
Multidose Regimen (MTX 1 mg/kg alternating with Leucovorin)
| Day | Action |
|---|---|
| Day 1, 3, 5, 7 | MTX 1 mg/kg IM; draw β-hCG on each dosing day |
| Day 2, 4, 6, 8 | Leucovorin 0.1 mg/kg IM (reduces toxicity) |
| Weekly | Once 15% drop achieved between any two consecutive values, stop MTX and monitor weekly |
- If β-hCG plateaus or rises during treatment, a second round (MTX + leucovorin) can be given 1 week later.
- ~54% need all 4 doses; ~10% require only 1 dose.
Signs That Mandate Surgical Intervention (Treatment Failure)
Monitor for these symptoms at every visit regardless of β-hCG trend:
- Acute abdominal pain, peritoneal signs, or hemodynamic instability → suspect rupture, go to surgery immediately
- β-hCG fails to fall after a second full course of MTX
- β-hCG plateaus for > 3 weeks without reaching non-pregnant level
Practical Monitoring Points
| Parameter | Timing |
|---|---|
| CBC, LFTs, creatinine | Repeated ~1 week after MTX administration |
| Pelvic ultrasound | Repeat only if clinical symptoms change; routine US during MTX therapy is not required |
| RhoGAM | Give if Rh-negative |
| Contraception | Patient should avoid pregnancy until β-hCG is undetectable |
| Avoid | NSAIDs, folic acid supplements, sun exposure, and alcohol during treatment |
Time to Resolution
Mean time to β-hCG resolution after single-dose MTX is approximately 5-6 weeks from administration, though this varies significantly with the initial β-hCG level. Higher starting levels take longer to resolve. A 2022 retrospective cohort study (PMID: 35609041) confirmed this, finding resolution time is closely tied to the baseline hCG level.
This is a shared conversation. Sign in to Orris to start your own chat.